TowardPi key facts
as of Oct 2026- Developer of ophthalmic medical equipment designed to detect and diagnose eye diseases.
- TowardPi is valued at approximately $22.8M as of Oct 2026, per PrivateMarketView’s mark.
- It has raised $253.4M; the latest was Later Stage VC ($58.1M) in Mar 2026.
- Notable investors include Qiming Venture Partners, Legend Capital, Beijing State-owned Capital Operation and Management, TusStar Incubator, Tsing Stone Asset Management — 27 tracked in total.
- 1 institutional filer reports fund marks on TowardPi across 2 filings.
- Status: Privately Held (backing).
Reported valuation; nothing comparable since.
- ·The complete investor list: 27 names
- ·Watch TowardPi: the Monday email on marks, rounds and moves
Institutional fund marks on TowardPi
1 filers · latest Jul 20261 SEC-registered fund reported 2 fair-value marks on TowardPi between Apr 2026 and Jul 2026. Filer-level marks and implied $/share are available to Pro members.
Membership and data by Private Market View
TowardPi funding rounds
No funding rounds for TowardPi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs TowardPi
27+Membership and data by Private Market View
TowardPi valuation
TowardPi is valued at approximately $22.8 million as of Oct 2026. The figure is set by institutional fund marks.
Recent activity
In the last 90 days, TowardPi's record added 1 institutional fund mark (latest period Jul 2026).
Institutional holders and vehicles
1 SEC-registered fund reported 2 fair-value marks on TowardPi between Apr 2026 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
TowardPi investors
27 investors are on record for TowardPi, including Qiming Venture Partners, Legend Capital, Beijing State-owned Capital Operation and Management and TusStar Incubator.
About TowardPi
Developer of ophthalmic medical equipment designed to detect and diagnose eye diseases. The company's equipment includes an optical coherence tomography (OCT) retinal diagnostic system, which can be used in non-invasive imaging tests and takes cross-sectional pictures of the patient's retina, enabling ophthalmologists to diagnose deformities or illnesses in the eye.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2017
- Employees
- 300
- Website
- towardpi.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.